Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)- methylarginine hydrochloride 546C88

Robert W. Harrison, Rajiv N. Thakkar, Hideaki Senzaki, Ulf E G Ekelund, Edward Cho, David A. Kass, Joshua Hare

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: The nitric oxide synthase inhibitor L-N(G)-methylarginine hydrochloride (L-NMMA HC1 546C88) causes reductions in cardiac output (CO), a potential limitation to clinical application. This drop in CO exceeds that from phenylephrine at matched systemic arterial pressure. We tested the hypothesis that the greater fall in CO attributable to L-NMMA primarily reflects a difference in venoconstriction between agents, such that phenylephrine produces larger increases in preload (an independent determinant of CO). Design: Random infusion of phenylephrine or L-NMMA. Setting: An animal research laboratory. Subjects: Eight healthy, conscious, male dogs. Interventions: L-N(G)-methylarginine hydrochloride (20 mg/kg for 1 hr) and phenylephrine (0.5 to 3 μg/kg/min) were administered into eight dogs chronically instrumented to measure left ventricular pressure and dimension. Data were measured at a constant heart rate (140 beats/min) to render CO proportional to stroke dimension. Measurements and Main Results: At a matched increase in afterload (effective arterial elastance), L-NMMA increased preload (end-diastolic dimension) to a lesser degree (3.8% ± 1.5%, p < .05) than phenylephrine (9.6% ± 1.6%, p < .05 vs. L-NMMA). Neither L-NMMA nor phenylephrine affected the slope of the end-systolic pressure dimension relationship, although L-NMMA shifted the relationship rightward (1.7 ± 0.7 mm, p < .05), consistent with a mild negative inotropic effect. L-NMMA decreased the stroke dimension to a greater extent than phenylephrine (-24.1% ± 6.8% and -10.6% ± 3.4%, respectively, p < .05). Conclusions: Differential CO responses to phenylephrine and L-NMMA were primarily attributable to changes in preload. Variable venular vs. arteriolar constrictor effects must be considered when evaluating the integrated cardiovascular response to a vasoactive agent.

Original languageEnglish
Pages (from-to)1263-1268
Number of pages6
JournalCritical Care Medicine
Volume28
Issue number5
StatePublished - Jun 9 2000
Externally publishedYes

Fingerprint

omega-N-Methylarginine
Nitric Oxide Synthase
Cardiac Output
Phenylephrine
Stroke
Dogs
Ventricular Pressure
Healthy Volunteers
Arterial Pressure
Heart Rate

Keywords

  • Cardiac output
  • L-N(G)-methylarginine hydrochloride
  • Myocardial contractility
  • Nitric oxide
  • Nitric-oxide synthase
  • Phenylephrine
  • Sepsis
  • Septic shock
  • Vascular endothelium
  • Vasoconstrictor agent

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)- methylarginine hydrochloride 546C88. / Harrison, Robert W.; Thakkar, Rajiv N.; Senzaki, Hideaki; Ekelund, Ulf E G; Cho, Edward; Kass, David A.; Hare, Joshua.

In: Critical Care Medicine, Vol. 28, No. 5, 09.06.2000, p. 1263-1268.

Research output: Contribution to journalArticle

Harrison, Robert W. ; Thakkar, Rajiv N. ; Senzaki, Hideaki ; Ekelund, Ulf E G ; Cho, Edward ; Kass, David A. ; Hare, Joshua. / Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)- methylarginine hydrochloride 546C88. In: Critical Care Medicine. 2000 ; Vol. 28, No. 5. pp. 1263-1268.
@article{23a9626c48e046b4949519fc9d76d3dc,
title = "Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)- methylarginine hydrochloride 546C88",
abstract = "Objective: The nitric oxide synthase inhibitor L-N(G)-methylarginine hydrochloride (L-NMMA HC1 546C88) causes reductions in cardiac output (CO), a potential limitation to clinical application. This drop in CO exceeds that from phenylephrine at matched systemic arterial pressure. We tested the hypothesis that the greater fall in CO attributable to L-NMMA primarily reflects a difference in venoconstriction between agents, such that phenylephrine produces larger increases in preload (an independent determinant of CO). Design: Random infusion of phenylephrine or L-NMMA. Setting: An animal research laboratory. Subjects: Eight healthy, conscious, male dogs. Interventions: L-N(G)-methylarginine hydrochloride (20 mg/kg for 1 hr) and phenylephrine (0.5 to 3 μg/kg/min) were administered into eight dogs chronically instrumented to measure left ventricular pressure and dimension. Data were measured at a constant heart rate (140 beats/min) to render CO proportional to stroke dimension. Measurements and Main Results: At a matched increase in afterload (effective arterial elastance), L-NMMA increased preload (end-diastolic dimension) to a lesser degree (3.8{\%} ± 1.5{\%}, p < .05) than phenylephrine (9.6{\%} ± 1.6{\%}, p < .05 vs. L-NMMA). Neither L-NMMA nor phenylephrine affected the slope of the end-systolic pressure dimension relationship, although L-NMMA shifted the relationship rightward (1.7 ± 0.7 mm, p < .05), consistent with a mild negative inotropic effect. L-NMMA decreased the stroke dimension to a greater extent than phenylephrine (-24.1{\%} ± 6.8{\%} and -10.6{\%} ± 3.4{\%}, respectively, p < .05). Conclusions: Differential CO responses to phenylephrine and L-NMMA were primarily attributable to changes in preload. Variable venular vs. arteriolar constrictor effects must be considered when evaluating the integrated cardiovascular response to a vasoactive agent.",
keywords = "Cardiac output, L-N(G)-methylarginine hydrochloride, Myocardial contractility, Nitric oxide, Nitric-oxide synthase, Phenylephrine, Sepsis, Septic shock, Vascular endothelium, Vasoconstrictor agent",
author = "Harrison, {Robert W.} and Thakkar, {Rajiv N.} and Hideaki Senzaki and Ekelund, {Ulf E G} and Edward Cho and Kass, {David A.} and Joshua Hare",
year = "2000",
month = "6",
day = "9",
language = "English",
volume = "28",
pages = "1263--1268",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)- methylarginine hydrochloride 546C88

AU - Harrison, Robert W.

AU - Thakkar, Rajiv N.

AU - Senzaki, Hideaki

AU - Ekelund, Ulf E G

AU - Cho, Edward

AU - Kass, David A.

AU - Hare, Joshua

PY - 2000/6/9

Y1 - 2000/6/9

N2 - Objective: The nitric oxide synthase inhibitor L-N(G)-methylarginine hydrochloride (L-NMMA HC1 546C88) causes reductions in cardiac output (CO), a potential limitation to clinical application. This drop in CO exceeds that from phenylephrine at matched systemic arterial pressure. We tested the hypothesis that the greater fall in CO attributable to L-NMMA primarily reflects a difference in venoconstriction between agents, such that phenylephrine produces larger increases in preload (an independent determinant of CO). Design: Random infusion of phenylephrine or L-NMMA. Setting: An animal research laboratory. Subjects: Eight healthy, conscious, male dogs. Interventions: L-N(G)-methylarginine hydrochloride (20 mg/kg for 1 hr) and phenylephrine (0.5 to 3 μg/kg/min) were administered into eight dogs chronically instrumented to measure left ventricular pressure and dimension. Data were measured at a constant heart rate (140 beats/min) to render CO proportional to stroke dimension. Measurements and Main Results: At a matched increase in afterload (effective arterial elastance), L-NMMA increased preload (end-diastolic dimension) to a lesser degree (3.8% ± 1.5%, p < .05) than phenylephrine (9.6% ± 1.6%, p < .05 vs. L-NMMA). Neither L-NMMA nor phenylephrine affected the slope of the end-systolic pressure dimension relationship, although L-NMMA shifted the relationship rightward (1.7 ± 0.7 mm, p < .05), consistent with a mild negative inotropic effect. L-NMMA decreased the stroke dimension to a greater extent than phenylephrine (-24.1% ± 6.8% and -10.6% ± 3.4%, respectively, p < .05). Conclusions: Differential CO responses to phenylephrine and L-NMMA were primarily attributable to changes in preload. Variable venular vs. arteriolar constrictor effects must be considered when evaluating the integrated cardiovascular response to a vasoactive agent.

AB - Objective: The nitric oxide synthase inhibitor L-N(G)-methylarginine hydrochloride (L-NMMA HC1 546C88) causes reductions in cardiac output (CO), a potential limitation to clinical application. This drop in CO exceeds that from phenylephrine at matched systemic arterial pressure. We tested the hypothesis that the greater fall in CO attributable to L-NMMA primarily reflects a difference in venoconstriction between agents, such that phenylephrine produces larger increases in preload (an independent determinant of CO). Design: Random infusion of phenylephrine or L-NMMA. Setting: An animal research laboratory. Subjects: Eight healthy, conscious, male dogs. Interventions: L-N(G)-methylarginine hydrochloride (20 mg/kg for 1 hr) and phenylephrine (0.5 to 3 μg/kg/min) were administered into eight dogs chronically instrumented to measure left ventricular pressure and dimension. Data were measured at a constant heart rate (140 beats/min) to render CO proportional to stroke dimension. Measurements and Main Results: At a matched increase in afterload (effective arterial elastance), L-NMMA increased preload (end-diastolic dimension) to a lesser degree (3.8% ± 1.5%, p < .05) than phenylephrine (9.6% ± 1.6%, p < .05 vs. L-NMMA). Neither L-NMMA nor phenylephrine affected the slope of the end-systolic pressure dimension relationship, although L-NMMA shifted the relationship rightward (1.7 ± 0.7 mm, p < .05), consistent with a mild negative inotropic effect. L-NMMA decreased the stroke dimension to a greater extent than phenylephrine (-24.1% ± 6.8% and -10.6% ± 3.4%, respectively, p < .05). Conclusions: Differential CO responses to phenylephrine and L-NMMA were primarily attributable to changes in preload. Variable venular vs. arteriolar constrictor effects must be considered when evaluating the integrated cardiovascular response to a vasoactive agent.

KW - Cardiac output

KW - L-N(G)-methylarginine hydrochloride

KW - Myocardial contractility

KW - Nitric oxide

KW - Nitric-oxide synthase

KW - Phenylephrine

KW - Sepsis

KW - Septic shock

KW - Vascular endothelium

KW - Vasoconstrictor agent

UR - http://www.scopus.com/inward/record.url?scp=0034126937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034126937&partnerID=8YFLogxK

M3 - Article

C2 - 10834663

AN - SCOPUS:0034126937

VL - 28

SP - 1263

EP - 1268

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 5

ER -